ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XGN vs BNR // RSI-14 & 200D SMA MOMENTUM

Exagen Inc. (NASDAQ) VS. Burning Rock Biotech Limited (NASDAQ) • 15-METRIC TALLY: XGN 3 — BNR 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: XGN
rsi-technicals
59.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XGN VS. BNR) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XGN BNR SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 58.30% 74.70% -16.40 BNR /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.77% -4.14% -2.63 BNR /fcf-yield <GO>
Operating Margin -21.10% -10.20% -10.90 BNR /operating-margins <GO>
Net Profit Margin -30.00% -10.30% -19.70 BNR /net-margins <GO>
Revenue Growth (YoY) 19.70% 9.20% +10.50 XGN /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 0.20 0.00 TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 BNR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 59.9 39.1 +20.80 XGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $210.8M $116.5M $94.2M XGN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XGN REV BNR REV XGN GROSS % BNR GROSS % XGN FCF BNR FCF
FY 2025 $66.6M $77.2M 58.3% 74.7% -$14.3M -$4.8M
FY 2024 $55.6M $70.7M 59.5% 70.3% -$13.8M -$13.4M
FY 2023 $52.5M $75.7M — — -$14.5M -$36.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XGN // BETA —
BNR // BETA —